Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 MAD Study of Anaprazole in Healthy Chinese Subjects
NCT04466748Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of Anaprazole in duodenal ulcer and gastroesophageal reflux disease (GERD) (4 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: Number of subjects with adverse events and serious adverse events at 15 days. Started Sep 2015; status: completed.
02
Drugs
Anaprazole
03
Conditions
duodenal ulcergastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04466748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04466748.